This document is a letter signed by 122 members of Congress urging the inclusion of Taiwan in the Indo-Pacific Economic Framework (IPEF). The letter argues that Taiwan should be invited to participate in IPEF as a major Indo-Pacific economy and important US trading partner. Taiwan's inclusion would demonstrate US support for allies and partners in the face of pressure from China, and Taiwan's expertise would enhance IPEF discussions and outcomes. The members of Congress strongly believe Taiwan should be at the front of the line for an IPEF invitation.
This document provides an interim distribution forecast for COVID-19 vaccines distributed through the COVAX Facility, including indicative distributions of AstraZeneca/Oxford vaccines for Q1-Q2 2021 and an exceptional first allocation of Pfizer-BioNTech vaccines for Q1 2021. It summarizes the number of doses that 145 participating countries can expect to receive initially based on current supply projections, to allow time for advance preparation. The allocations are non-binding and subject to change based on evolving variables and regulatory approvals.
This document is a letter signed by 122 members of Congress urging the inclusion of Taiwan in the Indo-Pacific Economic Framework (IPEF). The letter argues that Taiwan should be invited to participate in IPEF as a major Indo-Pacific economy and important US trading partner. Taiwan's inclusion would demonstrate US support for allies and partners in the face of pressure from China, and Taiwan's expertise would enhance IPEF discussions and outcomes. The members of Congress strongly believe Taiwan should be at the front of the line for an IPEF invitation.
This document provides an interim distribution forecast for COVID-19 vaccines distributed through the COVAX Facility, including indicative distributions of AstraZeneca/Oxford vaccines for Q1-Q2 2021 and an exceptional first allocation of Pfizer-BioNTech vaccines for Q1 2021. It summarizes the number of doses that 145 participating countries can expect to receive initially based on current supply projections, to allow time for advance preparation. The allocations are non-binding and subject to change based on evolving variables and regulatory approvals.
